Status
Conditions
Treatments
About
To assess whether holding incretin-based therapy before endoscopy reduces the likelihood of clinically relevant Residual Gastric Volume (RGV).
Primary Outcomes:
Secondary Outcomes:
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
120 participants in 2 patient groups
Loading...
Central trial contact
Tilak Shah, MD; Akram Ahmad, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal